ReviewFrontiers in immunology2026
The emerging roles of eosinophils in immune regulation in health and disease.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophils are evolutionarily conserved granular innate cells that can trace back to 100 million years to the emergence of gnathostomes, which now is involved in regulation of diverse homeostatic conditions and diseases in mammals. They have traditionally been associated with Th2 responses, primarily in eosinophilic allergic asthma and helminth parasitic infections. These Th2 responses are correlated with basic cationic proteins and specific cytokines release from preformed eosinophilic vesicles, associated with tissue damage and remodeling. Consequently, eosinophils have historically been characterized as potent cytotoxic effector cells. In human patients, their high blood count has been linked to clinical concerns and necessary further patient evaluations. However, this reflects only a cursory understanding of eosinophils, as their involvement in a broad and diverse range of disorders has recently emerged. Indeed, eosinophils extend beyond traditionally ascribed Th2 responses, which appear to be both global and pivotal in immune regulation contexts. Its role varies from speculative controlled embryological tissue modeling, to tissue regeneration post-injury, uncontrolled neoplastic development, novel Th2 eosinophilic gastrointestinal disorders, reproductive homeostasis and SARS-CoV-2 in a non-exhaustive list of its emerging association with health and disease. This review evaluates the emerging roles of eosinophils which are both pro- and anti-inflammatory, dependent on disease context and microenvironment. Our knowledge of the novel and diverse roles of eosinophils has been applied to the emergence of targeted, and successful clinical therapies to a range of diseases, opening doors to extend assessment on their potential roles in the original embryological modeling and development. Collectively, diverse modern evidence indicates that eosinophils-an ancient evolutionarily conserved cell lineage-has an imperative function in immune networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.